Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

4.31
+0.11002.62%
Post-market: 4.310.00000.00%19:30 EDT
Volume:1.37M
Turnover:5.90M
Market Cap:412.04M
PE:-3.58
High:4.40
Open:4.18
Low:4.15
Close:4.20
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:0.64
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.36
PE(LYR):-1.09

Loading ...

Myriad Genetics Finalizes Separation Agreement With Former CCO

TIPRANKS
·
4 hours ago

Myriad Genetics Ex-Chief Commercial Officer Brian Donnelly Exits Company Under Separation Agreement

Reuters
·
5 hours ago

Myriad, Sophia advance prostate cancer-specific genomic instability score tech

TIPRANKS
·
Oct 08

Myriad Genetics and Sophia Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

THOMSON REUTERS
·
Oct 08

Myriad Genetics is Maintained at Buy by Craig-Hallum

Dow Jones
·
Oct 03

Myriad Genetics price target raised to $8 from $4 at Craig-Hallum

TIPRANKS
·
Oct 02

Myriad Genetics EVP Commercial Vishal Sikri Files Initial Beneficial Ownership Statement

Reuters
·
Sep 18

Myriad Genetics Announces Key Commercial Leadership Transition

TIPRANKS
·
Sep 16

Myriad Genetics Names Vishal Sikri EVP, Commercial

Reuters
·
Sep 16

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

THOMSON REUTERS
·
Sep 16

Myriad Genetics is Maintained at Neutral by UBS

Dow Jones
·
Sep 10

UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating

MT Newswires Live
·
Sep 09

Myriad Genetics (MYGN) Gets a Hold from UBS

TIPRANKS
·
Sep 09

Myriad Genetics Shares Fall After Piper Sandler Downgrade

MT Newswires Live
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Myriad Genetics downgraded to Underweight from Overweight at Piper Sandler

TIPRANKS
·
Sep 01

Analyst Cuts Myriad Genetics to Sell, Slashes Price Target to $2 Amid Structural Profitability Concerns

TIPRANKS
·
Sep 01

Myriad Genetics Shares Down 4.3% Premarket After Piper Sandler Cuts to Underweight from Overweight

THOMSON REUTERS
·
Sep 01

Myriad Genetics, Inc. : Piper Sandler Cuts to Underweight from Overweight; Cuts Target Price to $2 from $5.45

THOMSON REUTERS
·
Sep 01